Covid-19 roundup: Stéphane Bancel sees December EUA for Moderna at earliest; Trump trashes Fauci as 'disaster' and 'idiot'
Stéphane Bancel’s new estimated timeline for Moderna’s Covid-19 vaccine puts his company on track to score an emergency use authorization in December — given the interim Phase results turn out positive in November.
Per the trial protocol, the first interim analysis of the Moderna vaccine’s efficacy will happen when 53 people in the entire study, which is enrolling 30,000 volunteers, get symptomatic disease. The data safety monitoring board would then review the unblinded results and check the breakdown between the vaccinated and those given placebo.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.